A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture
Open Access
- 13 May 2026
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 16 (10) , 2037-2059
Abstract
Muscle-invasive bladder cancer (MIBC) is clinically heterogeneous, and current molecular subtyping does not capture the spatial organization of tumor states and microenvironmental context. Here, we construct a spatial atlas of MIBC by integrating spatial transcriptomics from 22 tumors with matched bulk RNA and whole-exome sequencing data. We identify a continuous, spatially organized luminal-to-basal axis within individual tumors that is associated with greater chromosomal instability and transcriptional plasticity. Luminal tumor cores are enriched for FGFR3 and NECTIN4, whereas basal-like states localize toward invasive margins and are associated with elevated EGFR signaling, epithelial–mesenchymal transition, genomic instability, immune infiltration, and greater chemotherapy sensitivity. Spatial analyses further reveal lineage- and location-associated differences in tertiary lymphoid structure states. Pan-cohort analyses across over 3,000 tumors confirm conserved FGFR3–EGFR lineage exclusivity and associated immune programs. Together, these findings define a spatial framework for understanding lineage states, immune architecture, and therapeutic vulnerabilities in MIBC.Keywords
All Related Versions
Funding Information
- Center for Cancer Research (R01CA266280)
- Center for Cancer Research (U01CA294518)
- Cancer Prevention and Research Institute of Texas (RP200385)
- Center for Cancer Research (R01CA254988)
- Center for Cancer Research (R01CA269489)
- Center for Cancer Research (R01CA282282)
- Center for Cancer Research (R37CA288448)
- Center for Cancer Research (R01CA285454)
- Cancer Prevention and Research Institute of Texas (RP260133)
- Center for Cancer Research (R01CA258226)
- Center for Cancer Research (R01CA258886)
- Break Through Cancer
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (T32217789)
- U.S. Department of War (KC240237P1)
- U.S. Department of War (RA230062)
- Gateway for Cancer Research
- Kidney Cancer Association (Advanced Discovery Award)
- U.S. Department of War (HT942525-1-0047)
This publication has 70 references indexed in Scilit:
- Mature Tertiary Lymphoid Structures Indicate Good Chemotherapy Response and Prognosis in Advanced Colorectal CancerAnnals of Gastroenterological Surgery, 2025
- Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockadeCancer Cell, 2024
- NAMPT‐Driven M2 Polarization of Tumor‐Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal CancerAdvanced Science, 2024
- Integrated single‐cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial–fibroblast interactions in recurrent bladder cancerClinical and Translational Medicine, 2023
- Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancerCancer Communications, 2023
- The global burden of urinary bladder cancer: an updateWorld Journal of Urology, 2019
- Intrinsic subtypes and bladder cancer metastasisAsian Journal of Urology, 2016
- Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancerCancer and Metastasis Reviews, 2015
- Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumoursBreast Cancer Research and Treatment, 2012
- CXCR5‐ and CCR7‐dependent lymphoid neogenesis in a murine model of chronic antigen‐induced arthritisArthritis & Rheumatism, 2007